In a large-scale trial, modRNA was significantly better at preventing confirmed flu cases than a typical seasonal flu shot. Reading time 3 minutes Next-generation vaccines could make the flu season ...
Pfizer and BioNTech, makers of the Food and Drug Administration-approved COVID-19 vaccine Comirnaty, shared today that their vaccine is effective among children ages 5 to 11 and that they will seek ...
New research suggests that Pfizer’s COVID-19 vaccine can protect against a mutation found in two highly contagious variants of the coronavirus that erupted in Britain and South Africa. Those variants ...
Pfizer and Valenva are seeking regulatory approval from the Food and Drug Administration for a Lyme disease vaccine in development that's more than 70% effective against the tick-borne illness.
Morning Overview on MSN
The FDA approved a Pfizer RSV vaccine for at-risk adults as young as 18
Adults between 18 and 59 who face elevated risk of severe respiratory syncytial virus infection now have a licensed vaccine ...
Pfizer says its COVID-19 vaccine works for children ages 5 to 11. The vaccine maker said Monday it plans to seek authorization for this age group soon in the U.S., Britain and Europe. The vaccine made ...
Pfizer Inc announced an update on their ongoing clinical study. TipRanks Welcomes a New ETF – NYSE:RANK. TipRanks has entered a new arena in the investing world, powering the in ...
Discover top stock picks and new investment opportunities through TipRanks' Smart Investor Newsletter. Pfizer Inc. (PFE) is running a Phase 3 trial titled “A Phase 3, Randomized Double-Blind Trial to ...
New research suggests that Pfizer’s COVID-19 vaccine can protect against a mutation found in two highly contagious variants of the coronavirus that erupted in Britain and South Africa. Those variants ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results